Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Short term Debt: 2012-2025

Historic Short term Debt for Veracyte (VCYT) over the last 6 years, with Sep 2025 value amounting to $13.6 million.

  • Veracyte's Short term Debt rose 83.62% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year increase of 83.62%. This contributed to the annual value of $17.0 million for FY2024, which is 539.10% up from last year.
  • Veracyte's Short term Debt amounted to $13.6 million in Q3 2025, which was up 1.16% from $13.4 million recorded in Q2 2025.
  • Veracyte's 5-year Short term Debt high stood at $17.0 million for Q4 2024, and its period low was $2.6 million during Q3 2023.
  • Moreover, its 3-year median value for Short term Debt was $7.3 million (2024), whereas its average is $8.4 million.
  • As far as peak fluctuations go, Veracyte's Short term Debt tumbled by 56.47% in 2023, and later skyrocketed by 539.10% in 2024.
  • Over the past 5 years, Veracyte's Short term Debt (Quarterly) stood at $2.7 million in 2021, then spiked by 125.95% to $6.1 million in 2022, then crashed by 56.16% to $2.7 million in 2023, then soared by 539.10% to $17.0 million in 2024, then spiked by 83.62% to $13.6 million in 2025.
  • Its Short term Debt stands at $13.6 million for Q3 2025, versus $13.4 million for Q2 2025 and $14.4 million for Q1 2025.